Streeting promises UK pharma quick action on VPAG frustration
Streeting said his ten-year plan will address drug sale clawbacks, NICE regulation, and the abolition of NHS England.
Biopharmaceutical Industry
ABPI calls on UK Government to resolve “VPAG crisis”
Pharma industry dodges tariff blow but still braces for disruption
US uncertainty weighs on IPO market while UK innovation could benefit
Judge rejects J&J’s $9bn talc settlement for third time
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Saving shelved ultra-rare therapies through unorthodox funding
Big pharma faces headwinds in China as vaccine sales decline
